Once in circulation, M-MDSCs are recruited primarily through the CCL2/CCR2 axis, supported by CCL3 and CCL4, with cancer-associated fibroblasts amplifying this process by secreting CCL2 [28,30]. Here, CCL2 is linked to cancer.